✨ Free AI Report
Glooko, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Glooko, Inc.
Company Research

Glooko, Inc.: Business Overview, Financials & Competitive Analysis

Glooko, Inc. scores 8/10 on the AskCyborg Cyborg Score (Strong). Glooko is a clinically-driven digital health leader poised to capture growing demand for integrated glycemic management across hospital and outpatient care settings. Glooko demonstrates strong clinical validation, market recognition, and strategic positioning across both outpatient and inpatient diabetes care. Recent award recognition (May 2026) and significant funding ($524M raised) indicate.

What is Glooko, Inc.'s industry? Glooko, Inc. (glooko.com) operates in Digital Health. AskCyborg classifies Glooko, Inc. under Digital Health in its company registry.

Glooko, Inc. is a global digital health company focused on helping clinicians address the growing challenges of glycemic safety and diabetes management across the care continuum. The company is uniquely positioned to ...

8/ 10Strong

Cyborg Score thesis

Glooko is a clinically-driven digital health leader poised to capture growing demand for integrated glycemic management across...

Read the full analyst-debate transcript →
Industry Digital Health
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 21, 2026
AI-Verified Research
30+ Page Report

Get the Latest Glooko, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Glooko, Inc.

AskCyborg analysts argue the bull and bear cases for Glooko, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Glooko, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Glooko, Inc. Overview

Pro stress-test →

Glooko, Inc. is a global digital health company focused on helping clinicians address the growing challenges of glycemic safety and diabetes management across the care continuum. The company is uniquely positioned to be the enterprise partner of choice for healthcare providers seeking to reduce glycemic risk, improve safety, and support overburdened clinical teams with coordinated expertise across both outpatient and inpatient care settings.

Strategic Profile

Pro stress-test →

Glooko's suite of software solutions includes the Glooko diabetes management platform, EndoTool® Glucose Management System, Glooko XT, and the Glooko Mobile App, reflecting the company's focus on simplifying diabetes and glycemic management for healthcare providers, hospitals and health systems, and people living with diabetes. In May 2026, Glooko was selected as the winner of the "Best Overall MedTech Software" award in the 10th annual MedTech Breakthrough Awards program.

Competitive Landscape

Pro stress-test →

Glooko competes in the diabetes and glycemic management software space alongside vendors including Wellframe, Health2Sync, Apree Health, and GlySens. The company differentiates through a comprehensive software portfolio spanning remote patient monitoring, inpatient glucose management, and mobile engagement, plus clinical leadership and integration of acquired assets like Monarch Medical Technologies.

Industry Context

Glooko, Inc. operates in Digital Health.

Key facts

Founded: Unknown · Headquarters: Palo Alto, US · Employees: Unknown · Revenue: Not publicly available · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for Glooko, Inc..

  • Glooko has raised $524M in total funding with backing from strategic investors including Novo Nordisk, indicating strong confidence in the diabetes management digital health market and potential for continued expansion.
  • In May 2026, EndoTool IV (Glooko's inpatient glucose management system) demonstrated virtual elimination of severe hypoglycemia across 19 hospitals, directly addressing a critical patient safety metric in hospital diabetes care.
+1 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • May 2026Won 'Best Overall MedTech Software' award at 2026 MedTech Breakthrough Awards
  • May 2026Chief Medical and Strategy Officer Mark Clements named one of Becker's Healthcare's 2026 'Great leaders in healthcare'
  • +1 moreTrack every material event for Glooko, Inc. as it happens. Explore monitoring →
Get alerted when Glooko, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Health2SyncDiabetes management and remote monitoring→Apree HealthDigital diabetes care platform→One DropDigital diabetes management platform for remote patient monitoring→Livongo HealthChronic disease management including diabetes with connected devices→

Compare Glooko, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Glooko, Inc. operates in Digital Health. See how the rest of the sector scores on the Cyborg framework.

Browse Digital Health research →
NEW · MCP server

Ask your AI assistant about Glooko, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Glooko, Inc. and its top competitor on Cyborg Score”
“What did Glooko, Inc. do this quarter?”
“Is Glooko, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Glooko, Inc. do?+
Glooko, Inc. is a global digital health company focused on helping clinicians address the growing challenges of glycemic safety and diabetes management across the care continuum. The company is uniquely positioned to ...
What is Glooko, Inc.'s Cyborg Score?+
Glooko, Inc. has a Cyborg Score of 8/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Glooko, Inc.'s main competitors?+
Named competitors include Health2Sync, Apree Health, One Drop, Livongo Health. The full competitive landscape is in the AskCyborg report.
How can I get the full Glooko, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Glooko, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Glooko, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Digital Health research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7Hinge Health, Inc.7Owlet, Inc.4American Well Corporation4DocMorris AG3Hims & Hers Health, Inc.